RYTM position history
The shares of Rhythm Pharmaceuticals (RYTM) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q2: 362,000 shares, $1.5M, 0.68% of portfolio, New
- 2022 Q3: 810,000 shares, $20M, 8.2% of portfolio, Add +123.8%
- 2022 Q4: 735,000 shares, $21M, 7.4% of portfolio, Reduce −9.3%
- 2023 Q1: 735,000 shares, $13M, 3.9% of portfolio
- 2023 Q2: 735,000 shares, $12M, 2.9% of portfolio
- 2023 Q3: 653,000 shares, $15M, 4.9% of portfolio, Reduce −11.2%
- 2023 Q4: 610,000 shares, $28M, 7.5% of portfolio, Reduce −6.6%
- 2024 Q1: 1,030,000 shares, $45M, 10.0% of portfolio, Add +68.9%
- 2024 Q2: 515,000 shares, $21M, 4.8% of portfolio, Reduce −50.0%
- 2024 Q3: 500,000 shares, $26M, 4.4% of portfolio, Reduce −2.9%
- 2024 Q4: 500,000 shares, $28M, 4.9% of portfolio
- 2025 Q1: 490,000 shares, $26M, 5.8% of portfolio, Reduce −2.0%
- 2025 Q2: 950,000 shares, $60M, 12.1% of portfolio, Add +93.9%
- 2025 Q3: 461,700 shares, $47M, 6.6% of portfolio, Reduce −51.4%
- 2025 Q4: 660,000 shares, $71M, 9.3% of portfolio, Add +42.9%
- 2026 Q1: 123,000 shares, $35M, 4.7% of portfolio, Reduce −81.4%
- 2026 Q2: 122,500 shares, $14M, 1.2% of portfolio, Reduce −0.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|